BioSpring is a world-leading contract manufacturing and development organization for nucleic acid therapeutics. We provide end-to-end manufacturing and analytical solutions in our state-of-the-art cGMP-certified and FDA-inspected facilities for commercial therapies, clinical therapeutic development, diagnostics, and R&D. Over 25 years of know-how and experience stand behind our reputation of quality and innovation so our clients’ focus can stay on the cure. With a diverse, worldwide clientele from researchers to leading commercial drug developers, we are the trusted manufacturer and analytical expert for the next generation of nucleic acid therapeutics.